|Chemical and physical data|
|Molar mass||393.83 g·mol−1|
|3D model (JSmol)|
RAD140 is an investigational selective androgen receptor modulator (SARM) for the treatment of conditions such as muscle wasting and breast cancer, currently under development by Radius Health, Inc. (RDUS).
According to a study conducted by researchers at the University of Southern California, Los Angeles, RAD 140 appears to be safer than testosterone replacement therapy.
Another study conducted in February 2011 found that RAD 140 (Testolone) drastically increases lean muscle mass, by targeting androgen receptors in skeletal tissue.
While more research needs to be done, some recreational users report that RAD 140 can lead to rapid muscle gains, with minimal side effects.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|